Tag: Metabolic Diseases

April 21, 2026

Gut Microbial Dysbiosis Progresses from Health to Genetic Risk to Clinical Parkinson’s Disease, Correlating with Disease Severity

April 21, 2026

Ciltacabtagene Autoleucel CAR T Therapy for High-Risk Smoldering Multiple Myeloma

April 19, 2026

Reliability of LLMs as Medical Assistants for the General Public

April 19, 2026

Obicetrapib for Heterozygous Familial Hypercholesterolemia: BROOKLYN Trial Correction

April 18, 2026

HBG Promoter Editing for Sickle Cell and Beta-Thalassemia Treatment

April 18, 2026

Integrating Animal, Human, and AI Models for Enhanced Translational Research

April 16, 2026

Trabectedin and Irinotecan Combination Shows Promise for Ewing Sarcoma

April 16, 2026

Intestinal Metaplasia: The Single Precancer Pathway for Esophageal Carcinoma

April 16, 2026

Rapid Spread of H5N1 D1.1 Avian Influenza in Wild Birds and Humans

April 16, 2026

Small Intestinal Segments Support Auxiliary Liver Function

April 15, 2026

AcTau174: A Novel CSF Biomarker for FTLD-TDP Diagnosis and Progression

April 15, 2026

Proteomic Risk Score Predicts Kidney Disease Progression in APOL1 High-Risk Genotypes

April 15, 2026

Drug-Resistant Fungal Disease: A Priority for the 2026 Global Action Plan on AMR

April 15, 2026

Antibiotic Use Linked to Long-Term Gut Microbiome Alterations in Large Cohort Study

April 15, 2026

Setidegrasib Shows Promise for KRAS G12D-Driven Solid Tumors

April 14, 2026

KCNT1-Targeting Antisense Oligonucleotide Reduces Seizures but May Cause Hydrocephalus